Lynx, Glaxo Wellcome deal

Glaxo will terminate on March 17 a 1994 collaboration to develop Lynx's antisense drug to prevent restenosis following coronary angioplasty. The pharma company said the project no longer fit into the merged research portfolio of Glaxo and Wellcome. ...